Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Ottawa

$40,000.00

Synthesis and biosynthesis of polyketide natural products

FY 2012-13

Summary
Polyketide natural products are a major source of drugs to treat bacterial infections, and cancer. Developing efficient methods to synthesize these molecules and their analogs is necessary for understanding their mode of action, improving their pharmacological properties, and developing them as drugs. Polyketides are made by bacteria through modular, assembly line-like enzymatic pathways. It is possible to rationally reprogram these pathways to make new polyketides. This approach has the potential to revolutionize drug development and manufacturing, bringing new polyketide drugs to the market more rapidly with lower production costs. The major hurdle in reprogramming these pathways to produce designer polyketides is our limited understanding of how to access the broad structural diversity seen in polyketide natural products. Study of the enzymes involved in these pathways has characterized how only a subset of this diversity is constructed. This proposal focuses on developing new methods to increase the chemical diversity accessible from reprogrammed enzymatic pathways and training HQP at the interface of chemistry and biology. Two complementary approaches are used to extend the range of functional groups accessible by polyketide biosynthetic pathways. Enzymatic pathways can be programmed to build molecules containing reactive functional groups that can undergo spontaneous chemistry unmasking hitherto inaccessible chemical diversity. Using this approach, Ph.D, M.Sc. and undergraduate students will synthesize currently inaccessible functional groups in the anticancer agents spiculoic acid A and neopeltolide. A second approach focuses on engineering existing proteins to access new diversity. By characterized in detail the molecular interactions between protein and substrate, we will identify and modify amino acids responsible for controlling the regiochemical outcome of the critical ring forming enzymes from these pathways. HQP in this project will focus on accessing analogs of the antibiotic erythromycin and estrogenic metabolite zearalenone.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
371508-2009
Name nom
Boddy, Christopher
Department département
Chemistry
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2009
Award amount
40000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
24
Committee name en
Inorganic & Organic Chemistry
Committee name fr
Chimie inorg. et org.
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3703
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic syntheses
Research subject fr
Synthèses organiques
Partie
4
Nb partie
5
Application title
Synthesis and biosynthesis of polyketide natural products
Keyword
NSERC
Application summary
Polyketide natural products are a major source of drugs to treat bacterial infections, and cancer. Developing efficient methods to synthesize these molecules and their analogs is necessary for understanding their mode of action, improving their pharmacological properties, and developing them as drugs. Polyketides are made by bacteria through modular, assembly line-like enzymatic pathways. It is possible to rationally reprogram these pathways to make new polyketides. This approach has the potential to revolutionize drug development and manufacturing, bringing new polyketide drugs to the market more rapidly with lower production costs. The major hurdle in reprogramming these pathways to produce designer polyketides is our limited understanding of how to access the broad structural diversity seen in polyketide natural products. Study of the enzymes involved in these pathways has characterized how only a subset of this diversity is constructed. This proposal focuses on developing new methods to increase the chemical diversity accessible from reprogrammed enzymatic pathways and training HQP at the interface of chemistry and biology. Two complementary approaches are used to extend the range of functional groups accessible by polyketide biosynthetic pathways. Enzymatic pathways can be programmed to build molecules containing reactive functional groups that can undergo spontaneous chemistry unmasking hitherto inaccessible chemical diversity. Using this approach, Ph.D, M.Sc. and undergraduate students will synthesize currently inaccessible functional groups in the anticancer agents spiculoic acid A and neopeltolide. A second approach focuses on engineering existing proteins to access new diversity. By characterized in detail the molecular interactions between protein and substrate, we will identify and modify amino acids responsible for controlling the regiochemical outcome of the critical ring forming enzymes from these pathways. HQP in this project will focus on accessing analogs of the antibiotic erythromycin and estrogenic metabolite zearalenone.